Evofem Biosciences Competitors and Similar CompaniesClear all

Evofem Biosciences's competitors and similar companies include Revance Therapeutics, Anika Therapeutics and Hallura.

	Evofem Biosciences Evofem Biosciences, a clinical-stage biopharmaceutical company, develops and commercializes women’s sexual and reproductive health products.	Revance Therapeutics Revance Therapeutics is a biotechnology company that develops and commercializes aesthetic and therapeutic offerings.	Anika Therapeutics Anika Therapeutics develops, manufactures and commercializes therapeutic products for tissue protection, healing, and repair.	Hallura Hallura is an aesthetic medical company developing a new generation of hyaluronic acid (HA) dermal fillers.
Founding Date	Founding Date 2007	Founding Date 2002	Founding Date 1992	Founding Date 2017
Type	Type Public	Type Public	Type Public	Type Private
Tags	Tags Healthcare biotech drug development health & beauty	Tags Healthcare biotech drug development health & beauty	Tags Healthcare biotech drug development health & beauty	Tags Healthcare biotech drug development health & beauty
Locations	Locations San Diego, US HQ	Locations Nashville, US HQ Irvine, US Newark, US Pleasanton, US	Locations Bedford, US HQ Padova, IT Padova, IT Franklin, US	Locations Yokne'am Illit, IL HQ
Employees	Employees 3030% increase	Employees 59712% increase	Employees 15416% increase	Employees 215% increase
Valuation ($)	Valuation ($) 1.2 m	Valuation ($) 615.7 m	Valuation ($) 365 m	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $20.2m (FY, 2025)	Revenue (est.) $234m (FY, 2023)	Revenue (est.) $112.8m (FY, 2025)	Revenue (est.) N/A
Cost of goods	Cost of goods $4.6m (FY, 2025)	Cost of goods $74.4m (FY, 2023)	Cost of goods $49m (FY, 2025)	Cost of goods N/A
Gross profit	Gross profit $15.6m (FY, 2025)	Gross profit $159.7m (FY, 2023)	Gross profit $63.8m (FY, 2025)	Gross profit N/A
Net income	Net income $391k (FY, 2025)	Net income ($324m) (FY, 2023)	Net income ($10.9m) (FY, 2025)	Net income N/A